Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine
NCT ID: NCT01211028
Last Updated: 2017-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
13 participants
INTERVENTIONAL
2009-01-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.
NCT03968198
Autologous Adipose-Derived Stromal Cell Delivered Via Intramuscular Injections for the Treatment of Critical Limb Ischemia
NCT02099500
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
NCT02864654
Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
NCT01595776
Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD
NCT02756884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autologous ASCs
Expanded autologous ASCs (Adipose Stroma/Stem Cells) Intramuscular dose of 100 million expanded cells.
Expanded autologous ASCs
Drug: Expanded autologous adipose-derived adult stroma/stem cells
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Expanded autologous ASCs
Drug: Expanded autologous adipose-derived adult stroma/stem cells
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>40 years old
* Normal renal function (creatinine \< 1.6)
* Non pregnant female
* Lifespan \> 6 months
Exclusion Criteria
* Refusal to give informed consent and/orCognitively disabled
* Congestive heart failure or stroke in the last 3 months
* History of cancer or myeloproliferative disorders
* Proliferative retinopathy
* Pregnancy
* Positive screening test for HIV, Hepatitis B or Hepatitis C
* Buerger patient
* Cachexia or predicted impossibility for a biopsy of at least 30 grams of fat tissue
* Pregnancy or lactation
* Having been non controlled severe pathology
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Blood Establishment
OTHER
Clinical Research Center, Toulouse
OTHER
Centre National de la Recherche Scientifique, France
OTHER
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandra BURA-RIVIERE, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Toulouse, Rangueil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Toulouse, Rangueil
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004 Feb 10;109(5):656-63. doi: 10.1161/01.CIR.0000114522.38265.61. Epub 2004 Jan 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0405402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.